lilly tirzepatide Eli Launches Self-Pay Vials of for Patients With Obesity FDA says the tirzepatide weight-loss

A settlement that finalized in 2025 required Cerebral to pay out $5 million to aggrieved customers who could not cancel their subscriptions, as well as to cease misusing and improperly disclosing patient information, misrepresenting its data privacy or security practices and misrepresenting its cancellation practices. Now, it seems, Robertson is allegedly continuing these practices, with new companies, and new names

I am continuing to use the higher concentration Vitamin C serum to see if those new ones go away

If your symptoms persist beyond that, put the bottles down and see a professional

Longer than that, and you should evaluate whether the peptide is still viable

Is it safe to start anti-obesity medications early in treatment

Arch Biochem Biophys 2002